A subscription to JoVE is required to view this content. Sign in or start your free trial.
Method Article
Chronic ocular hypertension is induced using laser photocoagulation of the trabecular meshwork in mouse eyes. The intraocular pressure (IOP) is elevated for several months after laser treatment. The decrease of visual acuity and contrast sensitivity of experimental animals are monitored using the optomotor test.
Glaucoma, frequently associated with elevated intraocular pressure (IOP), is one of the leading causes of blindness. We sought to establish a mouse model of ocular hypertension to mimic human high-tension glaucoma. Here laser illumination is applied to the corneal limbus to photocoagulate the aqueous outflow, inducing angle closure. The changes of IOP are monitored using a rebound tonometer before and after the laser treatment. An optomotor behavioral test is used to measure corresponding changes in visual capacity. The representative result from one mouse which developed sustained IOP elevation after laser illumination is shown. A decreased visual acuity and contrast sensitivity is observed in this ocular hypertensive mouse. Together, our study introduces a valuable model system to investigate neuronal degeneration and the underlying molecular mechanisms in glaucomatous mice.
Procedures
C57BL/6J mice (Jackson Laboratory, Bar Harbor, ME) are raised at Northwestern University's Animal Care Facility. All animals are used in accordance with protocols approved by Northwestern University Institutional Animal Care and Use Committee and conformed to the guidelines on the Use of Animals in Neuroscience Research from the NIH.
1. Laser Photocoagulation
The procedure of laser photocoagulation is modified from previously published protocols 5-7.
2. IOP Measurements
3. Optomotor Test
Visual acuity and contrast sensitivity are tested 14,15 . The two eyes of individual mice are examined separately by reversing the drifting grating direction; i.e. a clockwise drifting grating is used to identify the visual function of the left eye and a counter-clockwise drifting grating for the right eye 16. Each test takes about 15 min and is repeated by two observers independently.
As described in the Procedures, laser illumination is aimed at the trabecular meshwork in the limbal region to photocoagulate the aqueous outflow, inducing angle closure (Figure 1). Most lasered eyes exhibited no significant physical damage, pigment detachment or infection, consistent with previous findings 6. When a small group of mice (less than 5% of all lasered animals) exhibited physical signs of severe damage such as deflated eye balls, severe cataract, significant pigment detachment, or...
We report above that sustained ocular hypertension can be induced by laser illumination in mouse eyes. Compared to the saline injection model 18 and the vein cautery model 11 both of which require extensive microsurgical skills, the laser illumination is relatively simple and easy to perform. Usually we can perform the laser illumination for 4-6 mice in 2-3 hr. The critical steps to achieve sustained IOP elevation are the anterior chamber flattening before laser and the parameters for laser illumina...
The authors declare that they have no competing financial interests.
The authors are full-time employees of Northwestern University.
The authors received NO funding that was provided by companies which produce reagents and instruments used in this article.
The work contained in this paper has been supported by the Dr. Douglas H. Johnson Award for Glaucoma Research from the American Health Assistance Foundation (XL), the William & Mary Greve Special Scholar Award from the Research to Prevent Blindness (XL), the Illinois Society for the Prevention of Blindness (HC) and NIH grant R01EY019034 (XL).
Name | Company | Catalog Number | Comments |
Reagent | |||
moxifloxacin | Alcon Labs, Inc. | NDC 0065-4013-03 | 0.5 %, Rx only |
Proparacaine Hydrochloride | Bausch & Lomb | NDC 24208-730-06 | 0.5 %, Rx only |
Ophthalmic Solution USP | Bausch & Lomb | NDC 24208-730-06 | .5 %, Rx only |
ketamine | Butler Schein Animal Health | NDC 11695-0550-1 | 100 mg / kg |
xylazine | LLOYD Inc. of Iowa | NADA 139-236 | 10 mg / kg |
atropine sulfate solution | Alcon Labs, Inc. | NDC 61314-303-02 | 1 %, Rx only |
Equipment | |||
Slit Lamp, TOPCON | Visual Systems Inc | SL-3E | powered by PS-30A |
OptoMotry 1.8.0 virtual | CerebralMechanics Inc. | ||
opto-kinetic testing system | CerebralMechanics Inc. | ||
Tonometer, TonoLab, for mice | Colonial Medical Supply | ||
Heating pad | Sunbeam Products Inc | 722-810 | |
Argon laser | Coherent Inc | Ultima 2000SE | |
DECAPICONE Plastic cone holder | Braintree Sci Inc. | MDC-200 | for mouse |
Request permission to reuse the text or figures of this JoVE article
Request PermissionThis article has been published
Video Coming Soon
Copyright © 2025 MyJoVE Corporation. All rights reserved